Inefficiencies in viral vector production, particularly the inability to distinguish between full and empty capsids during purification, are hindering gene therapy development. This bottleneck increases manufacturing costs and delays patient access to treatments. Researchers are developing advanced materials and machine learning tools to improve purification efficiency and reduce process times, aiming to make gene therapies more accessible and affordable.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



